Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.215 USD | -0.79% | +6.49% | -67.00% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 288M |
---|---|---|---|---|---|
Net income 2024 * | -129M | Net income 2025 * | -164M | EV / Sales 2024 * | - |
Net cash position 2024 * | 132M | Net cash position 2025 * | 181M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.65
x | P/E ratio 2025 * |
-2.67
x | Employees | 131 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92% |
Latest transcript on RAPT Therapeutics, Inc.
1 day | -0.60% | ||
1 week | +5.08% | ||
Current month | +7.53% | ||
1 month | +4.81% | ||
3 months | -67.89% | ||
6 months | -40.17% | ||
Current year | -66.68% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 15-07-31 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 19-12-01 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 22-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 19-12-03 |
William Rieflin
CHM | Chairman | 64 | 15-04-30 |
Wendye Robbins
BRD | Director/Board Member | 63 | 19-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 237 M€ | +3.55% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 8.19 | -1.09% | 23 725 |
24-05-06 | 8.28 | -0.60% | 298,961 |
24-05-03 | 8.33 | +2.52% | 587,552 |
24-05-02 | 8.125 | -0.67% | 780,115 |
24-05-01 | 8.18 | +6.23% | 1,088,380 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.68% | 288M | |
+9.15% | 106B | |
-1.08% | 104B | |
+6.96% | 23.25B | |
-11.55% | 22.5B | |
-7.10% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- RAPT Stock